全球qPCR试剂市场规模、份额、趋势和成长分析报告（2026-2034年）

预计 qPCR 试剂市场将从 2025 年的 39.5 亿美元成长到 2034 年的 84.7 亿美元，2026 年至 2034 年的复合年增长率为 8.84%。

由于全球对分子诊断检测的需求不断增长，全球qPCR试剂市场正经历显着增长。感染疾病的蔓延推动了临床检查室检测量的增加，而基因组学和生物技术领域研究活动的拓展也促进了试剂的消耗。此外，新冠疫情也加速了人们对先进分子诊断技术的认知与应用。这些因素共同推动了整体市场成长。

关键驱动因素包括个人化医疗和精准诊断的进步。製药和生物技术公司在药物研发和检验过程中高度依赖qPCR技术。政府对生命科学研究投入的增加带动了检查室投资的成长。技术进步提高了检测的灵敏度、准确性和可靠性。新兴经济体诊断基础设施的不断改善也支撑了市场需求。

由于在癌症治疗和基因检测领域的应用不断扩展，未来前景仍然光明。实验室自动化将显着提高处理能力和效率。多种检测方法的开发有望带来更多成长机会。新兴市场对医疗基础设施的投资正在不断加强。分子生物学工具的持续创新可望支撑其长期发展。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球qPCR试剂市场：依产品类型划分

• 市场分析、洞察与预测
• 母带混音
• 引子和探针
• 酵素
• 缓衝
• 其他的

第五章：全球qPCR试剂市场：依应用划分

• 市场分析、洞察与预测
• 临床诊断
• 药物研究
• 环境监测
• 农业生物技术
• 食品安全检查

第六章：全球qPCR试剂市场：依技术划分

• 市场分析、洞察与预测
• 即时PCR（qPCR）
• 数位PCR（dPCR）
• 多重PCR
• 逆转录聚合酵素链锁反应（RT-PCR）

第七章：全球qPCR试剂市场：依最终用户划分

• 市场分析、洞察与预测
• 学术研究机构
• 製药和生物技术公司
• 医院和诊所
• 诊断实验室
• 受託研究机构（CRO）

第八章 全球qPCR试剂市场：依等级划分

• 市场分析、洞察与预测
• 研究级
• 临床等级
• 符合监管规定的等级

第九章 全球qPCR试剂市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 以色列
  • 南非
  • 其他中东和非洲国家

第十章 竞争格局

• 最新趋势
• 公司分类
• 供应链和分销通路合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十一章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Roche
  • Thermo Fisher
  • Cole-Parmer
  • Norgen BIoTek
  • Promega
  • Qiagen
  • Sigma-Aldrich
  • Takara Bio

The qPCR Reagents Market size is expected to reach USD 8.47 Billion in 2034 from USD 3.95 Billion (2025) growing at a CAGR of 8.84% during 2026-2034.

The global qPCR reagents market is growing significantly due to increasing demand for molecular diagnostic testing worldwide. Rising prevalence of infectious diseases has boosted testing volumes in clinical laboratories. Expanding research activities in genomics and biotechnology are driving reagent consumption. The pandemic accelerated awareness and adoption of advanced molecular diagnostic technologies. These combined factors are strengthening overall market growth.

Key drivers include advancements in personalized medicine and precision diagnostics. Pharmaceutical and biotechnology companies rely heavily on qPCR for drug development and validation processes. Growing government funding for life science research is increasing laboratory investments. Technological improvements have enhanced assay sensitivity, accuracy, and reliability. Expansion of diagnostic infrastructure in emerging economies further supports demand.

Future prospects remain promising with increasing applications in oncology and genetic testing. Automation in laboratories will significantly improve throughput and efficiency. Development of multiplex assays will offer additional growth opportunities. Emerging markets are strengthening healthcare infrastructure investments. Continuous innovation in molecular biology tools will sustain long-term expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Master Mix
• Primers and Probes
• Enzymes
• Buffers
• Other Components

By Application

• Clinical Diagnostics
• Pharmaceutical Research
• Environmental Monitoring
• Agricultural Biotechnology
• Food Safety Testing

By Technology

• Real-Time PCR (qPCR)
• Digital PCR (dPCR)
• Multiplex PCR
• Reverse Transcription PCR (RT-PCR)

By End User

• Academic and Research Institutions
• Pharmaceutical and Biotechnology Companies
• Hospitals and Clinics
• Diagnostic Laboratories
• Contract Research Organizations (CROs)

By Grade

• Research Grade
• Clinical Grade
• Regulatory Compliant Grade

COMPANIES PROFILED

• Agilent Technologies, BioRad Laboratories, Roche, Thermo Fisher, ColeParmer, Norgen Biotek, Promega, Qiagen, SigmaAldrich, Takara Bio
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL QPCR REAGENTS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Master Mix Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Primers and Probes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Enzymes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Buffers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Other Components Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL QPCR REAGENTS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Clinical Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Pharmaceutical Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Environmental Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Agricultural Biotechnology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Food Safety Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL QPCR REAGENTS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Technology
• 6.2. Real-Time PCR (qPCR) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Digital PCR (dPCR) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Multiplex PCR Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Reverse Transcription PCR (RT-PCR) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL QPCR REAGENTS MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Academic and Research Institutions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Pharmaceutical and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Hospitals and Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Contract Research Organizations (CROs) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL QPCR REAGENTS MARKET: BY GRADE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Grade
• 8.2. Research Grade Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Clinical Grade Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Regulatory Compliant Grade Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL QPCR REAGENTS MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product Type
  • 9.2.2 By Application
  • 9.2.3 By Technology
  • 9.2.4 By End User
  • 9.2.5 By Grade
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product Type
  • 9.3.2 By Application
  • 9.3.3 By Technology
  • 9.3.4 By End User
  • 9.3.5 By Grade
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product Type
  • 9.4.2 By Application
  • 9.4.3 By Technology
  • 9.4.4 By End User
  • 9.4.5 By Grade
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product Type
  • 9.5.2 By Application
  • 9.5.3 By Technology
  • 9.5.4 By End User
  • 9.5.5 By Grade
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product Type
  • 9.6.2 By Application
  • 9.6.3 By Technology
  • 9.6.4 By End User
  • 9.6.5 By Grade
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL QPCR REAGENTS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Agilent Technologies
  • 11.2.2 Bio-Rad Laboratories
  • 11.2.3 Roche
  • 11.2.4 Thermo Fisher
  • 11.2.5 Cole-Parmer
  • 11.2.6 Norgen Biotek
  • 11.2.7 Promega
  • 11.2.8 Qiagen
  • 11.2.9 Sigma-Aldrich
  • 11.2.10 Takara Bio